Irrational use of antibiotics and factors associated with antibiotic resistance: Findings from a cross-sectional study in Bangladesh.
Bangladesh
antimicrobial resistance
irrational use of drugs
regression analysis
Journal
Health science reports
ISSN: 2398-8835
Titre abrégé: Health Sci Rep
Pays: United States
ID NLM: 101728855
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
15
04
2023
revised:
11
07
2023
accepted:
19
07
2023
medline:
31
7
2023
pubmed:
31
7
2023
entrez:
31
7
2023
Statut:
epublish
Résumé
Irrational antibiotic (AB) usage poses a serious concern to third-world countries because of poor surveillance, lack of information, and patients' propensity for self-medication. Additionally, the unpredictability of the coronavirus disease 2019 (COVID-19) pandemic promoted the abuse of ABs, which accelerated the prevalence of antibiotic resistance (ABR). The primary aim of this study was to assess the pattern of AB usage and irrational use of ABs-related potential factors associated with ABR among the students and teachers of a leading public university of Bangladesh. A cross-sectional web-based survey was conducted among the students and teachers ( The regression analysis supported that male participants had a 34% lower experience of acquiring ABR than female respondents (adjusted odds ratio [AOR] = 0.66, 95% confidence interval [CI] = 0.448, 0.973; This study found that irrational use of ABs is more prevalent among the youth and female participants. At this stage, there is an urgent need for comprehensive statutory AB control rules, as well as measures for appropriate information, education, and surveillance throughout different groups of Bangladesh.
Sections du résumé
Background and aims
UNASSIGNED
Irrational antibiotic (AB) usage poses a serious concern to third-world countries because of poor surveillance, lack of information, and patients' propensity for self-medication. Additionally, the unpredictability of the coronavirus disease 2019 (COVID-19) pandemic promoted the abuse of ABs, which accelerated the prevalence of antibiotic resistance (ABR). The primary aim of this study was to assess the pattern of AB usage and irrational use of ABs-related potential factors associated with ABR among the students and teachers of a leading public university of Bangladesh.
Methods
UNASSIGNED
A cross-sectional web-based survey was conducted among the students and teachers (
Results
UNASSIGNED
The regression analysis supported that male participants had a 34% lower experience of acquiring ABR than female respondents (adjusted odds ratio [AOR] = 0.66, 95% confidence interval [CI] = 0.448, 0.973;
Conclusion
UNASSIGNED
This study found that irrational use of ABs is more prevalent among the youth and female participants. At this stage, there is an urgent need for comprehensive statutory AB control rules, as well as measures for appropriate information, education, and surveillance throughout different groups of Bangladesh.
Identifiants
pubmed: 37520458
doi: 10.1002/hsr2.1465
pii: HSR21465
pmc: PMC10375841
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e1465Informations de copyright
© 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Int J Infect Dis. 2016 Oct;51:89-96
pubmed: 27575938
J Infect Public Health. 2021 Dec;14(12):1750-1766
pubmed: 34756812
Nat Rev Microbiol. 2015 Jan;13(1):42-51
pubmed: 25435309
J Antimicrob Chemother. 2020 Jul 1;75(7):1681-1684
pubmed: 32433765
Front Microbiol. 2013 Mar 12;4:47
pubmed: 23487476
Antibiotics (Basel). 2020 Aug 09;9(8):
pubmed: 32784880
BJU Int. 2019 Mar;123(3):401-410
pubmed: 30537407
Int J Antimicrob Agents. 2005 Aug;26(2):106-13
pubmed: 16009535
J Antimicrob Chemother. 2016 Jul;71(7):1800-6
pubmed: 27040304
BMC Public Health. 2019 Jan 15;19(1):66
pubmed: 30646892
J Infect Dis. 2008 Oct 1;198(7):962-70
pubmed: 18710327
BMC Public Health. 2014 Aug 14;14:847
pubmed: 25124712
J Antimicrob Chemother. 2002 Dec;50 Suppl S2:39-43
pubmed: 12556432
Bull World Health Organ. 2020 Jul 1;98(7):442-442A
pubmed: 32742026
Clin Infect Dis. 2020 Dec 17;71(10):2736-2743
pubmed: 32361747
BMJ Open. 2018 Feb 22;8(2):e020203
pubmed: 29472269
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
JAC Antimicrob Resist. 2020 Sep;2(3):dlaa049
pubmed: 34192248
Antimicrob Resist Infect Control. 2020 Jul 11;9(1):105
pubmed: 32653034
Eur J Cancer. 2007 Aug;43(12):1810-20
pubmed: 17689070
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470
pubmed: 29581252
Ann Clin Microbiol Antimicrob. 2014 Apr 22;13:15
pubmed: 24755269
Antibiotics (Basel). 2020 Nov 17;9(11):
pubmed: 33212785
Curr Opin Microbiol. 2020 Oct;57:95-101
pubmed: 33147565
J Pharm Policy Pract. 2020 Apr 22;13:7
pubmed: 32337049
Asia Pac J Public Health. 2021 Jan;33(1):141-144
pubmed: 33242975
Asian Pac J Trop Biomed. 2014 Apr;4(4):306-11
pubmed: 25182556